Contributors

Headshot
Co-host

Dr. Randy Vogenberg

Dr. Randy Vogenberg is a distinguished healthcare strategist known for his expertise in clinical effectiveness, healthcare economics, and regulatory policy innovation. With a professional career spanning decades, he has led multi-million-dollar projects and significantly improved the quality of care for millions. His insights on economic outcomes and policy are globally cited with almost 200 publications and over 150 citations in books or other journal articles, making him a trusted healthcare voice. As a translational academic and integrated care thought leader, he has provided strategic solutions to healthcare organizations, health plans, and mid-size to Fortune 500 companies. Dr. Vogenberg currently serves as the Board Chair for the Employer-Provider Council of the Hospital Quality Foundation. Learn more about Randy by visiting iih-online.com. 

https://iih-online.com/
Headshot
Co-host

MICHAEL NAVIN

Michael Navin is a serial entrepreneur focused on disrupting the healthcare industry for the better.  He founded his first healthcare venture, Element Marketing Group, EMG, launching 150+ pharmaceutical brand products. EMG also developed a software known as Element Access–a proprietary digitized pull-through detail aid that was the first of its kind in the industry. In 2014 EMG was acquired by WPP, under the Ogilvy Health umbrella, with the explicit purpose of growing the Element Access platform and expanding their managed markets footprint in the United States. As a result, multiple unique brands utilize this platform with great success.  After his time with Ogilvy, he founded Peek Healthcare Technologies Inc with the mission of making pharmaceuticals and healthcare more accessible and affordable for the patient. 

https://peekmeds.com/about/

Guests

Headshot
Guest

Stan Mehr

Stan Mehr is a veteran clinical and health policy writer with 35+ years of experience in pharma, managed care, and healthcare publishing. He specializes in translating complex topics like drug pricing, reimbursement, and market access into actionable insights. As founder and editor of Biosimilars Review & Report (www.biosimilarsrr.com), Stan is a leading voice on biosimilars, FDA approvals, and healthcare reform. His work bridges editorial expertise with strategic consulting—helping stakeholders navigate policy shifts and optimize access to affordable therapies.

https://biosimilarsrr.com/

Guest appearance on: